Gergen Mark J - Insider Non-Derivative Transactions at Poseida Therapeutics, Inc. (PSTX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jan 8, 2025, Gergen Mark J's relationship to Poseida Therapeutics, Inc. (PSTX) is Director,Officer (President and CEO), and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other PSTX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Gergen Mark J - Insider Non-Derivative Transactions of PSTX Common Stock

Gergen Mark J - Insider Non-Derivative Transactions at PSTX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jan 9, 2025	U -- (Common Stock)	636726	0	0
Jan 3, 2025	F -- (Common Stock)	23313	9.6	630726
Dec 11, 2024	Sell -- (Common Stock)	30000	9.46	651291
Dec 11, 2024	M -- (Common Stock)	30000	2.78	681291
Nov 27, 2024	Sell -- (Common Stock)	30000	9.27	651291
Nov 27, 2024	M -- (Common Stock)	30000	2.78	681291
Mar 2, 2024	F -- (Common Stock)	34157	4.13	651291
Feb 2, 2024	F -- (Common Stock)	47162	3.41	685448
Jan 3, 2024	Acquisition -- (Common Stock)	125000	0	732610
Mar 2, 2023	Acquisition -- (Common Stock)	269586	0	601610
Feb 2, 2023	F -- (Common Stock)	31819	7	330314